# FDA recall D-175-2013

> **Actavis Pharmaceuticals** · Class III · drug recall initiated 2013-01-04.

## Product

buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217

## Reason for recall

Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-175-2013
- **Recalling firm:** Actavis Pharmaceuticals
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-01-04
- **Report date:** 2013-03-06
- **Termination date:** 2014-01-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Morristown, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-175-2013

## Citation

> AI Analytics. FDA recall D-175-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-175-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*